🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is no standard treatment for chondrosarcoma. Some small sample of stu...
Status
Unknown
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-02-06
Trial ID
NCT05193188
Treatments Being Tested
Anlotinib is a multi-target receptor tyrosine kinase inhibitor in domestic ...
Status
Unknown
Location
Multiple Locations
Start Date
2018-11-30
Trial ID
NCT03750916
Treatments Being Tested
Research purposes: the research design in the late more than 2 lines TNBC p...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2024-12-06
Trial ID
NCT06878625
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
This is an single-arm, multicenter phase II study to evaluate the safety an...
Status
Not Yet Recruiting
Location
West China Hospital of Sichuan University
Start Date
2026-04-01
Trial ID
NCT07501169
Treatments Being Tested
The goal of this clinical trial is to compare the efficacy and safety of in...
Status
Not Yet Recruiting
Location
ThirdXiangyaHCSU
Start Date
2026-05-15
Trial ID
NCT07643350
Treatments Being Tested
To compare the effects and safety of Anlotinib with placebo in patients wit...
Status
Completed
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2015-07
Trial ID
NCT02586350
What is this study about? This is a medical research study testing a new dr...
Status
Recruiting
Location
Shanghai Sixth Peolple'S Hospital
Start Date
2025-12-25
Trial ID
NCT07359053
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
A randomized, double-blind, controlled, multicenter phase III study of TQB2...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-01
Trial ID
NCT04234607
Treatments Being Tested